U.S. Govt to Buy More Regeneron Covid-19 Antibody Cocktail Doses

New agreement covers 1.25m additional doses, bringing total potential U.S. supply to >1.5m doses, Regeneron says.

Agreement value as much as $2.625b
Doses are being supplied for use pursuant to the FDA Emergency Use Authorization for high-risk patients with mild to moderate Covid-19 in order to reduce the risk of progression to severe Covid-19 and/or hospitalization

To view the source of this information click here

To contact the reporter on this story:
Jim Silver in New York at jsilver@bloomberg.net

To contact the editor responsible for this story:
Maria Jose Valero at mvalero3@bloomberg.net

To read the full article log in.